Hunan Jingfeng Pharmaceutical Co.,Ltd. (000908.SZ)
- Previous Close
5.1400 - Open
5.4800 - Bid --
- Ask 5.1400 x --
- Day's Range
5.1400 - 5.5500 - 52 Week Range
0.7200 - 6.3600 - Volume
5,515,800 - Avg. Volume
22,095,043 - Market Cap (intraday)
4.293B - Beta (5Y Monthly) --
- PE Ratio (TTM)
30.50 - EPS (TTM)
0.1600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 23, 2018
- 1y Target Est
--
Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmology and API products, as well as engages in the research and development of anti-tumor, cancer, and cardiovascular drugs; and provides skin care products. In addition, the company provides CDMO/CMO services. The company was founded in 2003 and is headquartered in Shanghai, China.
www.jfzhiyao.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 000908.SZ
View MorePerformance Overview: 000908.SZ
Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000908.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000908.SZ
View MoreValuation Measures
Market Cap
4.29B
Enterprise Value
4.69B
Trailing P/E
30.33
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.38
Price/Book (mrq)
61.42
Enterprise Value/Revenue
11.27
Enterprise Value/EBITDA
24.34
Financial Highlights
Profitability and Income Statement
Profit Margin
36.61%
Return on Assets (ttm)
-0.21%
Return on Equity (ttm)
--
Revenue (ttm)
416.03M
Net Income Avi to Common (ttm)
152.3M
Diluted EPS (ttm)
0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
85.52M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-7.67M